{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T21:28:07Z","timestamp":1794432487385,"version":"4.9.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000861","name":"Burroughs Wellcome Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000861","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["K08CA222663"],"award-info":[{"award-number":["K08CA222663"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["U54CA225088"],"award-info":[{"award-number":["U54CA225088"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA013696"],"award-info":[{"award-number":["P30CA013696"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Genet"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1038\/s41588-021-00779-1","type":"journal-article","created":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T12:02:45Z","timestamp":1614600165000},"page":"332-341","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":302,"title":["Multimodal pooled Perturb-CITE-seq screens in patient models define mechanisms of cancer immune evasion"],"prefix":"10.1038","volume":"53","author":[{"given":"Chris J.","family":"Frangieh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes C.","family":"Melms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratiksha I.","family":"Thakore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6705-0681","authenticated-orcid":false,"given":"Kathryn R.","family":"Geiger-Schuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4622-8188","authenticated-orcid":false,"given":"Patricia","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrienne M.","family":"Luoma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Cleary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4037-386X","authenticated-orcid":false,"given":"Livnat","family":"Jerby-Arnon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruti","family":"Malu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Cuoco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryann","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casey R.","family":"Ager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0314-5323","authenticated-orcid":false,"given":"Meri","family":"Rogava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lila","family":"Hovey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asaf","family":"Rotem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantale","family":"Bernatchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai W.","family":"Wucherpfennig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce E.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orit","family":"Rozenblatt-Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3524-7858","authenticated-orcid":false,"given":"Dirk","family":"Schadendorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3293-3158","authenticated-orcid":false,"given":"Aviv","family":"Regev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2379-6702","authenticated-orcid":false,"given":"Benjamin","family":"Izar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,1]]},"reference":[{"key":"779_CR1","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1016\/j.cell.2016.11.038","volume":"167","author":"A Dixit","year":"2016","unstructured":"Dixit, A. et al. Perturb-seq: dissecting molecular circuits with scalable single-cell RNA profiling of pooled genetic screens. Cell 167, 1853\u20131866 (2016).","journal-title":"Cell"},{"key":"779_CR2","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1016\/j.cell.2016.11.048","volume":"167","author":"B Adamson","year":"2016","unstructured":"Adamson, B. et al. A multiplexed single-cell CRISPR screening platform enables systematic dissection of the unfolded protein response. Cell 167, 1867\u20131882 (2016).","journal-title":"Cell"},{"key":"779_CR3","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/nmeth.4177","volume":"14","author":"P Datlinger","year":"2017","unstructured":"Datlinger, P. et al. Pooled CRISPR screening with single-cell transcriptome readout. Nat. Methods 14, 297\u2013301 (2017).","journal-title":"Nat. Methods"},{"key":"779_CR4","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1016\/j.cell.2016.11.039","volume":"167","author":"DA Jaitin","year":"2016","unstructured":"Jaitin, D. A. et al. Dissecting immune circuits by linking CRISPR-pooled screens with single-cell RNA-seq. Cell 167, 1883\u20131896 (2016).","journal-title":"Cell"},{"key":"779_CR5","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/s41592-019-0392-0","volume":"16","author":"EP Mimitou","year":"2019","unstructured":"Mimitou, E. P. et al. Multiplexed detection of proteins, transcriptomes, clonotypes and CRISPR perturbations in single cells. Nat. Methods 16, 409\u2013412 (2019).","journal-title":"Nat. Methods"},{"key":"779_CR6","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1126\/science.aaa8172","volume":"348","author":"P Sharma","year":"2015","unstructured":"Sharma, P. & Allison, J. P. The future of immune checkpoint therapy. Science 348, 56\u201361 (2015).","journal-title":"Science"},{"key":"779_CR7","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1056\/NEJMoa1604958","volume":"375","author":"JM Zaretsky","year":"2016","unstructured":"Zaretsky, J. M. et al. Mutations associated with acquired resistance to PD-1 blockade in melanoma. N. Engl. J. Med. 375, 819\u2013829 (2016).","journal-title":"N. Engl. J. Med."},{"key":"779_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01062-w","volume":"8","author":"M Sade-Feldman","year":"2017","unstructured":"Sade-Feldman, M. et al. Resistance to checkpoint blockade therapy through inactivation of antigen presentation. Nat. Commun. 8, 1136 (2017).","journal-title":"Nat. Commun."},{"key":"779_CR9","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.cell.2018.09.006","volume":"175","author":"L Jerby-Arnon","year":"2018","unstructured":"Jerby-Arnon, L. et al. A cancer cell program promotes T cell exclusion and resistance to checkpoint blockade. Cell 175, 984\u2013997 (2018).","journal-title":"Cell"},{"key":"779_CR10","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nature23477","volume":"548","author":"SJ Patel","year":"2017","unstructured":"Patel, S. J. et al. Identification of essential genes for cancer immunotherapy. Nature 548, 537\u2013542 (2017).","journal-title":"Nature"},{"key":"779_CR11","unstructured":"Kearney, C. J. et al. Tumor immune evasion arises through loss of TNF sensitivity. Sci. Immunol. 3, eaar3451 (2018)."},{"key":"779_CR12","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1126\/science.aao1710","volume":"359","author":"D Pan","year":"2018","unstructured":"Pan, D. et al. A major chromatin regulator determines resistance of tumor cells to T cell-mediated killing. Science 359, 770\u2013775 (2018).","journal-title":"Science"},{"key":"779_CR13","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/nature23270","volume":"547","author":"RT Manguso","year":"2017","unstructured":"Manguso, R. T. et al. In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target. Nature 547, 413\u2013418 (2017).","journal-title":"Nature"},{"key":"779_CR14","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1158\/2159-8290.CD-15-0283","volume":"6","author":"W Peng","year":"2016","unstructured":"Peng, W. et al. Loss of PTEN promotes resistance to T cell-mediated immunotherapy. Cancer Discov. 6, 202\u2013216 (2016).","journal-title":"Cancer Discov."},{"key":"779_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00449-z","volume":"8","author":"RM Mbofung","year":"2017","unstructured":"Mbofung, R. M. et al. HSP90 inhibition enhances cancer immunotherapy by upregulating interferon response genes. Nat. Commun. 8, 451 (2017).","journal-title":"Nat. Commun."},{"key":"779_CR16","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1093\/jnci\/djx257","volume":"110","author":"JA McKenzie","year":"2018","unstructured":"McKenzie, J. A. et al. The effect of topoisomerase I inhibitors on the efficacy of T-cell-based cancer immunotherapy. J. Natl Cancer Inst. 110, 777\u2013786 (2018).","journal-title":"J. Natl Cancer Inst."},{"key":"779_CR17","doi-asserted-by":"publisher","first-page":"3366","DOI":"10.1158\/1078-0432.CCR-17-2483","volume":"24","author":"L Huang","year":"2018","unstructured":"Huang, L. et al. The RNA-binding protein MEX3B mediates resistance to cancer immunotherapy by downregulating HLA-A expression. Clin. Cancer Res. 24, 3366\u20133376 (2018).","journal-title":"Clin. Cancer Res."},{"key":"779_CR18","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/nmeth.4380","volume":"14","author":"M Stoeckius","year":"2017","unstructured":"Stoeckius, M. et al. Simultaneous epitope and transcriptome measurement in single cells. Nat. Methods 14, 865\u2013868 (2017).","journal-title":"Nat. Methods"},{"key":"779_CR19","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.it.2017.12.005","volume":"39","author":"A Veillette","year":"2018","unstructured":"Veillette, A. & Chen, J. SIRP\u03b1\u2013CD47 immune checkpoint blockade in anticancer therapy. Trends Immunol. 39, 173\u2013184 (2018).","journal-title":"Trends Immunol."},{"key":"779_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08637-9","volume":"10","author":"LM Myers","year":"2019","unstructured":"Myers, L. M. et al. A functional subset of CD8+ T cells during chronic exhaustion is defined by SIRP\u03b1 expression. Nat. Commun. 10, 794 (2019).","journal-title":"Nat. Commun."},{"key":"779_CR21","unstructured":"Zhang, W. et al. Advances in anti-tumor treatments targeting the CD47\/SIRP\u03b1 Axis. Front. Immunol. 11, 18 (2020)."},{"key":"779_CR22","doi-asserted-by":"publisher","first-page":"11613","DOI":"10.1073\/pnas.90.24.11613","volume":"90","author":"AR Arulanandam","year":"1993","unstructured":"Arulanandam, A. R. et al. The CD58 (LFA-3) binding site is a localized and highly charged surface area on the AGFCC\u2019C\u201d face of the human CD2 adhesion domain. Proc. Natl Acad. Sci. USA 90, 11613\u201311617 (1993).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"779_CR23","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nrc3239","volume":"12","author":"DM Pardoll","year":"2012","unstructured":"Pardoll, D. M. The blockade of immune checkpoints in cancer immunotherapy. Nat. Rev. Cancer 12, 252\u2013264 (2012).","journal-title":"Nat. Rev. Cancer"},{"key":"779_CR24","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nri3191","volume":"12","author":"NP Restifo","year":"2012","unstructured":"Restifo, N. P., Dudley, M. E. & Rosenberg, S. A. Adoptive immunotherapy for cancer: harnessing the T cell response. Nat. Rev. Immunol. 12, 269\u2013281 (2012).","journal-title":"Nat. Rev. Immunol."},{"key":"779_CR25","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1038\/ni.3558","volume":"17","author":"Q Chen","year":"2016","unstructured":"Chen, Q., Sun, L. & Chen, Z. J. Regulation and function of the cGAS-STING pathway of cytosolic DNA sensing. Nat. Immunol. 17, 1142\u20131149 (2016).","journal-title":"Nat. Immunol."},{"key":"779_CR26","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.iotech.2019.10.001","volume":"3","author":"S Agrawal","year":"2019","unstructured":"Agrawal, S. & Kandimalla, E. R. Intratumoural immunotherapy: activation of nucleic acid sensing pattern recognition receptors. Immunooncol. Technol. 3, 15\u201323 (2019).","journal-title":"Immunooncol. Technol."},{"key":"779_CR27","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.cell.2016.08.069","volume":"167","author":"J Gao","year":"2016","unstructured":"Gao, J. et al. Loss of IFN-\u03b3 pathway genes in tumor cells as a mechanism of resistance to Anti-CTLA-4 therapy. Cell 167, 397\u2013404 (2016).","journal-title":"Cell"},{"key":"779_CR28","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.ccr.2011.11.006","volume":"20","author":"M Challa-Malladi","year":"2011","unstructured":"Challa-Malladi, M. et al. Combined genetic inactivation of \u03b22-microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphoma. Cancer Cell 20, 728\u2013740 (2011).","journal-title":"Cancer Cell"},{"key":"779_CR29","doi-asserted-by":"publisher","first-page":"477","DOI":"10.4049\/jimmunol.1401917","volume":"195","author":"J Leitner","year":"2015","unstructured":"Leitner, J., Herndler-Brandstetter, D., Zlabinger, G. J., Grubeck-Loebenstein, B. & Steinberger, P. CD58\/CD2 is the primary costimulatory pathway in human CD28\u2013CD8+ T cells. J. Immunol. 195, 477\u2013487 (2015).","journal-title":"J. Immunol."},{"key":"779_CR30","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/j.1365-2567.2011.03470.x","volume":"134","author":"M Strioga","year":"2011","unstructured":"Strioga, M., Pasukoniene, V. & Characiejus, D. CD8+CD28\u2013 and CD8+CD57+ T cells and their role in health and disease. Immunology 134, 17\u201332 (2011).","journal-title":"Immunology"},{"key":"779_CR31","doi-asserted-by":"publisher","unstructured":"Boyeau, P. et al. Deep generative models for detecting differential expression in single cells. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/794289 (2019).","DOI":"10.1101\/794289"},{"key":"779_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-015-0843-6","volume":"16","author":"W Li","year":"2015","unstructured":"Li, W. et al. Quality control, modeling, and visualization of CRISPR screens with MAGeCK-VISPR. Genome Biol. 16, 281 (2015).","journal-title":"Genome Biol."},{"key":"779_CR33","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/s41592-020-0905-x","volume":"17","author":"B Li","year":"2020","unstructured":"Li, B. et al. Cumulus provides cloud-based data analysis for large-scale single-cell and single-nucleus RNA-seq. Nat. Methods 17, 793\u2013798 (2020).","journal-title":"Nat. Methods"},{"key":"779_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-017-1382-0","volume":"19","author":"FA Wolf","year":"2018","unstructured":"Wolf, F. A., Angerer, P. & Theis, F. J. SCANPY: large-scale single-cell gene expression data analysis. Genome Biol. 19, 15 (2018).","journal-title":"Genome Biol."},{"key":"779_CR35","unstructured":"Pedregosa, F. et al. Scikit-learn: machine learning in Python. J. Mach. Learn. Res. 12, 2825\u20132830 (2011)."},{"key":"779_CR36","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1214\/12-AOS1018","volume":"40","author":"P-L Loh","year":"2012","unstructured":"Loh, P.-L. & Wainwright, M. J. High-dimensional regression with noisy and missing data: provable guarantees with nonconvexity. Ann. Stat. 40, 1637\u20131664 (2012).","journal-title":"Ann. Stat."}],"container-title":["Nature Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41588-021-00779-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41588-021-00779-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41588-021-00779-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T18:24:26Z","timestamp":1684607066000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41588-021-00779-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["779"],"URL":"https:\/\/doi.org\/10.1038\/s41588-021-00779-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.09.01.267211","asserted-by":"object"}]},"ISSN":["1061-4036","1546-1718"],"issn-type":[{"value":"1061-4036","type":"print"},{"value":"1546-1718","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"13 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A. Regev is a cofounder and equity holder of Celsius Therapeutics, an equity holder in Immunitas and, until 31\u2009July 2020, was an SAB member of Thermo Fisher Scientific, Syros Pharmaceuticals, Neogene Therapeutics and Asimov. From 1\u2009August 2020, A. Regev has been an employee of Genentech. B.I. is a consultant for Merck and Volastra Therapeutics. B.E.J. is on the scientific advisory board of Checkpoint Therapeutics. From 16\u2009November 2020,\u2009K.G.S. and O.R.-R. have been employees of Genentech. A. Rotem is a consultant to eGenesis, a SAB member of NucleAI and an equity holder in Celsius Therapeutics. Since 31\u2009August 2020, A. Rotem has been an employee of AstraZeneca. K.W.W. serves on the scientific advisory board of TCR2 Therapeutics, T-Scan Therapeutics, SQZ Biotech and Nextechinvest and receives sponsored research funding from Novartis. K.W.W. is a cofounder of Immunitas, a biotech company. These activities are not related to the research reported in this publication. C.B. is on the scientific advisory board of Myst Therapeutics. A. Regev, B.I., J.C.M., K.R.G.-S., P.I.T. and C.J.F. are inventors on a patent application related to this work.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}